Dual Endothelin Type A Receptor/Ang II Subtype 1 Receptor Antagonist (DEARA)

All categories

DBCAT005808Pharmacologic class

A DrugBank category of 1 drug. 1 of them is approved.

Drugs: Sparsentan

What you can answer from here — as of February 21, 2023

1DrugEach linked to its full drug card

Listed above

3Drug targetsEvery drug–target pair in the class, with bond type

2Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Dual Endothelin Type A Receptor/Ang II Subtype 1 Receptor Antagonist (DEARA) share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account